Pacific Biosciences Of California (PACB) Other financing activities (2019 - 2026)

Pacific Biosciences Of California has reported Other financing activities for 8 years, with the latest figure at $255000.0 in Q2 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $255000.0 in Q2 2026; TTM through Jun 2026 was $3.2 million, a 14.07% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, down 55.5% from the prior year.
• Other financing activities was $255000.0 for Q2 2026 at Pacific Biosciences Of California, down from $1.4 million in the prior quarter.
• The five-year high for Other financing activities was $7.2 million in Q1 2023, with the low at $255000.0 in Q2 2026.
• Average Other financing activities over 5 years is $2.8 million, with a median of $1.7 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Other financing activities jumped 204.95% in 2023, then sank 82.2% in 2024.
• Over 5 years, Other financing activities stood at $1.2 million in 2022, then slipped by 24.94% to $936000.0 in 2023, then declined by 13.25% to $812000.0 in 2024, then soared by 80.91% to $1.5 million in 2025, then tumbled by 82.64% to $255000.0 in 2026.
• The last three Other financing activities figures came in at $255000.0 (Q2 2026), $1.4 million (Q1 2026), and $1.5 million (Q3 2025), per Business Quant data.